Research output per year
Research output per year
Personal profile
External positions
Medical University of Vienna
Fingerprint
Dive into the research topics where Winfried F. Pickl is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Differential decline of SARS-CoV-2-specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID-19
Kratzer, B., Gattinger, P., Trapin, D., Ettel, P., Körmöczi, U., Rottal, A., Stieger, R. B., Sehgal, A. N. A., Feichter, M., Borochova, K., Tulaeva, I., Grabmeier-Pfistershammer, K., Tauber, P. A., Perkmann, T., Fae, I., Wenda, S., Kundi, M., Fischer, G. F., Valenta, R. & Pickl, W. F., 14 Jul 2024, (E-pub ahead of print) In: Allergy: European Journal of Allergy and Clinical Immunology. 79, 9, p. 2482-2501 20 p.Research output: Journal article (peer-reviewed) › Journal article
Open Access -
Flow Cytometry-Based Measurement of Antibodies Specific for Cell Surface-Expressed Folded SARS-CoV-2 Receptor-Binding Domains
Sehgal, A. N. A., Safran, J., Kratzer, B., Gattinger, P., Stieger, R. B., Musiejovsky, L., Trapin, D., Ettel, P., Körmöczi, U., Rottal, A., Borochova, K., Dorofeeva, Y., Tulaeva, I., Weber, M., Grabmeier-Pfistershammer, K., Perkmann, T., Wiedermann, U., Valenta, R. & Pickl, W. F., 01 Apr 2024, In: Vaccines. 12, 4, 377.Research output: Journal article (peer-reviewed) › Journal article
Open Access -
Macropinocytosis Is the Principal Uptake Mechanism of Antigen-Presenting Cells for Allergen-Specific Virus-like Nanoparticles
Kraus, A., Kratzer, B., Sehgal, A. N. A., Trapin, D., Khan, M., Boucheron, N. & Pickl, W. F., 18 Jul 2024, In: Vaccines. 12, 7, 797.Research output: Journal article (peer-reviewed) › Journal article
Open Access -
The T-Cell Growth Factor Interleukin-2, Which Is Occasionally Targeted by Autoantibodies, Qualifies as Drug for the Treatment of Allergy, Autoimmunity, and Cancer: Collegium Internationale Allergologicum (CIA) Update 2024
Sehgal, A. N. A., Tauber, P. A., Stieger, R. B., Kratzer, B. & Pickl, W. F., 2024, In: International Archives of Allergy and Immunology. 185, 3, p. 286-300 15 p.Research output: Journal article (peer-reviewed) › Review article
Open Access -
Vaccine Based on Recombinant Fusion Protein Combining Hepatitis B Virus PreS with SARS-CoV-2 Wild-Type- and Omicron-Derived Receptor Binding Domain Strongly Induces Omicron-Neutralizing Antibodies in a Murine Model
Gattinger, P., Kratzer, B., Sehgal, A. N. A., Ohradanova-Repic, A., Gebetsberger, L., Tajti, G., Focke-Tejkl, M., Schaar, M., Fuhrmann, V., Petrowitsch, L., Keller, W., Högler, S., Stockinger, H., Pickl, W. F. & Valenta, R., 23 Feb 2024, In: Vaccines. 12, 3, 229.Research output: Journal article (peer-reviewed) › Journal article
Open Access1 Citation (Scopus)
Activities
- 1 Organising an event (Science to science)
-
Karl Landsteiner Symposium: From B cells to antibodies
Valenta, R. (Organiser) & Pickl, W. F. (Organiser)
10 Jul 2023Activity: Participating in/organising an event › Organising an event (Science to science)
File